Fresh Equities
Offers
Learn
RESMED INC
ASX:RMD

RESMED INC

Health Care

Resmed Inc. (RMD) is a global company involved in the development, manufacturing and marketing of medical products for the treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. RMD sells a range of products in approximately 100 countries worldwide through direct offices and a network of distributors.

Read more

Market Cap

8.30b

Price at Close

$23.37

4w avg. Volume

1.39m

4w avg. Turnover

$33.72m

Announcements
announcementt+2 movementdate
  • Chess Depositary Interest - RMD

    Issued Capital

  • -2.43%

    02 Sep 2020

-2.43%

02 Sep 2020
  • Update - Dividend/Distribution - RMD

    Dividend Announcement

  • -1.27%

    23 Aug 2020

-1.27%

23 Aug 2020
  • Form S-8

    Issued Capital · Market sensitive

  • +0.37%

    13 Aug 2020

+0.37%

13 Aug 2020
  • Resmed Form 10-K Annual Report

    Periodic Reports

  • +0.37%

    13 Aug 2020

+0.37%

13 Aug 2020
  • Dividend/Distribution - RMD

    Dividend Announcement · Market sensitive

  • -0.33%

    11 Aug 2020

-0.33%

11 Aug 2020
  • FORM 8-K

    Periodic Reports · Market sensitive

  • -10.34%

    05 Aug 2020

-10.34%

05 Aug 2020
  • Chess Depositary Interest - RMD

    Issued Capital

  • -10.11%

    04 Aug 2020

-10.11%

04 Aug 2020
  • RMD to Report Fourth Quarter Fiscal 2020 Results

    Other

  • +0.92%

    16 Jul 2020

+0.92%

16 Jul 2020
  • Chess Depositary Interest - RMD

    Issued Capital

  • -1.34%

    06 Jul 2020

-1.34%

06 Jul 2020
  • Chess Depositary Interest - RMD

    Issued Capital

  • -0.56%

    03 Jun 2020

-0.56%

03 Jun 2020
Market Data

Current Price

$23.37

52WK HIGH

$29.3

52WK LOW

$18.1

1YR RETURN

+19.42%

1YR RETURN VS. SECTOR

-22.14%

90 DAY RETURN

-9.42%

ASX RANK

50

/2,019

SECTOR RANK

3

/28

SHARES OUTSTANDING

355.16m
ASX:RMD

RESMED INC

Health Care

Resmed Inc. (RMD) is a global company involved in the development, manufacturing and marketing of medical products for the treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. RMD sells a range of products in approximately 100 countries worldwide through direct offices and a network of distributors.

Read more

Market Cap

8.30b

Price at Close

$23.37

4w avg. Volume

1.39m

4w avg. Turnover

$33.72m

ASX:RMD is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Support

Ask Fresh

Archive
Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.